CSF1R and amyloidosis: Additionally, when the number of DAM was reduced by the treatment of colony-stimulating factor 1 receptor (CSF1R) inhibitor, amyloid-related pathology was ameliorated, further confirming the therapeutic relevance of proinflammatory DAM in AD [209].